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ON THE HILL
Kidney Transplantation:
Beacon of Hope
By Harriet Jackson Scarupa
For 10 years and 3 months now Scottie Leftdwrige has been walking around with the kidney of a dead stranger implanted in
his body.
The 45-year-old Howard University 
Hospital medical aide is the first person to 
have received a kidney transplant from 
the hospital’s transplant center.
His transplant followed a period when 
he was so weak he couldn’t walk two 
blocks without stopping to rest, when his 
weight dropped alarmingly because he 
was unable to keep food in his stomach, 
when his urine was tainted with blood, his 
heartbeat irregular, his whole body 
wracked by nausea. One night, when the 
nausea drove him nearly out of his mind, 
he sought out a doctor. The diagnosis: 
kidney failure.
When kidneys fail because of disease, 
damage, or some congenital abnormality, 
the body does not excrete enough water, 
salt and other substances. This causes 
the volume of water in the body to in­
crease and tissues to swell. Without med­
ical intervention— dialysis or a transplant 
— the composition of body fluids will 
change steadily until it becomes so ab­
normal that death will ensue.
For 10 months Leftdwrige was on 
dialysis — a time-consuming process of 
cleansing the blood through an artificial 
kidney machine. When the nephrologist 
[kidney specialist] who was treating him 
suggested he consider a transplant, 
Leftdwrige was frightened by the idea of 
an operation at first. But when he consid­
ered the alternative—being hooked up to 
a dialysis machine for 12 or more hours a 
week and then still feeling weak much of 
the time, having to make do on a severely 
restricted diet, not even being able to 
drink a glass of water whenever he felt 
like it — he decided to chance the opera­
tion. “I just wanted to get better,” he 
recalls.
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weeks after the transplant, he was dis­
charged from the hospital. Gradually his 
strength returned. Gradually he was able 
to resume working, though in a new job in 
the central supply section of the hospital 
instead of in his old job at a laundry. Today, 
he says, except for not being able to lift 
heavy objects, he can do just about every­
thing he could before kidney disease 
struck him down.
Recently Leftdwrige participated in a 
group therapy session which the Howard 
transplant center runs for past, present 
and future transplant recipients. As the 
session began, the nurse leading it asked 
the patients to share some of their posit­
ive thoughts of the day. When it was 
Leftdwrige’s turn, the soft-spoken, re­
served father of six willingly obliged: T m  
thankful for being able to work, for being 
able to do things I couldn’t do on the 
[dialysis] machine. I’m thankful my appe­
tite’s much better and that I don’t have as 
much sickness. I’m thankful I’m able to 
live a normal life. ”
Scottie Leftdwrige’s experience repre­
sents the up side of the kidney transplan­
tation story. So do the experiences of 
many of the center’s other patients. Peo­
ple like Vernita Howard, who’s had “her” 
kidney for nine years now, she proudly 
tells you, and even more proudly tells you 
that she’s been able to give birth to a 
healthy child. Or Ronald Norris, who re­
ceived a transplant eight years ago and 
later went on to win first place in the 
150-meter run at a special Olympics in 
Athens, Greece, for transplant patients 
from all over the world. Or Alvin Brown, a 
three-time kidney recipient, who founded 
a group to help make the hospital stays of 
low-income transplant patients more 
comfortable and to educate the larger 
public about kidney disease and trans­
plantation. Or Tomeka Batey, who was 
transformed from a listless invalid to an
Scottie Leftdwrige (left), the first person to receive a transplant from the Howard transplant center with 
Reather Felton, head nurse of the Howard University Hospital’s dialysis unit.
active schoolgirl after she received a kid­
ney from her mother six months ago. 
[See Box, “A Mother’s Story.”]
But there’s another side to the trans­
plantation story. The down side. A week 
after Leftdwrige shared his blessings 
about being able to live a normal life in 
that meeting room on the hospital’s fourth 
floor, another kind of drama was taking 
place in a basement intensive care unit. 
There 27-year-old Denise Chasten, who 
made medical history in October 1982 by 
being the first woman with sickle cell dis­
ease and a kidney transplant to have a 
baby, had just been admitted as a patient. 
She was lying on a bed hooked up to a 
dialysis machine while an electrocardiog­
raph was monitoring her heart and new 
entries were rapidly being penned on her 
medications chart. Her manner was 
lethargic, her breathing labored, her 
jowls heavy with excess fluid.
Denise Chasten was in the midst of a 
rejection episode, her body reacting to 
her transplanted kidney—the second one 
she’d received in three years — as if it 
were some hostile foreign invader that 
must be attacked. The rejection action 
had caused the potassium level in her 
bloodstream to shoot up and if the pre­
scribed medication wasn’t able to bring it 
down, her heart could be endangered. 
Her condition: critical.
Two sides of the same sto ry . . .  Yes, 
kidney transplantation offers the dazzling 
promise of a better quality of life to those 
whose own kidneys have failed. In fact,
since the first successful transplant was 
performed in 1954 on identical twins at 
Peter Bent Brigham Hospital in Boston, 
Mass., thousands of transplant opera­
tions have been done with increasing 
rates of success.
But kidney transplantation isn’t always 
the answer. Sometimes it doesn’t work 
and even when it does work there is the 
ever-present threat of rejection and the 
often troublesome side effects from the 
drugs recipients must take to prevent 
that rejection.
Who Decides?
“All I do with patients is give them the 
pros and the cons,” says Dr. Clive 
Callender, the noted transplant surgeon 
who serves as director of the Howard 
University Hospital Transplant Center. “I 
don’t tell anyone, ‘You must have a trans­
plant. ’ I say, These are the pros. These 
are the cons. What do you want?”’
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Since 1974, Howard’s center 
has performed about 160 
transplants...
The patients attending that group 
therapy session seemed united in their 
view that they would willingly undergo 
one, two, even more transplants, if nec­
essary, if it meant freedom from that 
dreaded [dialysis] machine. (A social 
worker assigned to the center points out 
that there are also patients who do well on 
dialysis and who choose to continue this 
mode of treatment even if they would be 
good transplant candidates.) “The mortal­
ity rate for patients who have transplants 
is about the same as for those on 
dialysis/’ Dr. Callender says. “The big 
difference is that the quality of life after 
transplantation is generally so improved.”
A further note on the mortality ques­
tion: Previously the average life span of a 
person on dialysis was considered to be 
10 years. But with improvements in the 
procedure, that life span has been ex­
tended significantly. Those involved in 
treating patients who are on dialysis or 
have transplants shy away from making 
any blanket predictions about how long 
such patients will be able to live, pointing 
out that so much depends on individual 
variables — a person’s overall health be­
fore being struck with kidney disease, 
conscientious adherence to doctor’s or­
ders, heredity, lifestyle, will to live . . .  
Some people on dialysis or with a trans­
plant have lived for years and years, 
others for weeks.
The allure of being able to enjoy an en­
hanced quality of life helps explain why 
the number of patients in the nation await­
ing transplants continues to exceed the 
number of available organs. The general 
thinking among many involved in trans­
plantation is that 30 percent of all patients 
who are on dialysis are potential candi­
dates for transplantation. As for the pres­
ent state of affairs: A report prepared by 
the Forum of Network Coordinating 
Councils, which facilitates the exchange 
of information among the nation’s end
stage renal disease networks, noted that 
in 1982 [the most recent year for which it 
released figures] there were 5,358 trans­
plants performed in the nation’s trans­
plant centers, while 6,720 people were on 
transplant center waiting lists. Of the 
total transplants performed that year, 
3,681 of the kidneys came from cadavers,
i.e. from people who recently had died, 
while 1,677 came from living relatives of 
patients.
Donations from living relatives have a 
much higher success rate than those from 
cadavers. A National Kidney Foundation 
publication points out that when the 
transplanted kidney comes from a closely 
matched brother or sister, for example, 
the long-term chances of that kidney 
functioning are about 90 percent. When 
the kidney comes from an unrelated dead 
person — as is still the case with most 
kidney transplants — the success rate 
drops to between 50 and 60 percent two 
years after the transplant. (Comprehen­
sive statistics are not kept for a longer 
period.)
Since Scottie Leftdwrige’s transplant 
on January 28, 1974, Howard’s center has 
performed about 160 transplants, with 
about 20 percent of these involving dona­
tions from relatives — with none of the 
donors experiencing any problems.
Of those patients who received trans­
plants at Howard, 50 percent are still alive 
with functioning kidneys, 25 percent have 
returned to dialysis, while the other 25 
percent have died from causes related di­
rectly or indirectly to kidney problems. 
Dr. Callender shares these figures, then 
goes on to add a pointed footnote: “I think 
our statistics compare with the national 
averages. But I don’t deal with that issue 
[of comparisons]. It’s like comparing ap­
ples and oranges because most centers 
have predominantly white patients and 
our patients are Black. ”
As he had testified last October before
a Senate committee holding hearings on a 
proposed organ transplant bill:
“Blacks who suffer from end stage 
renal disease and who require dialysis and 
transplantation are a unique group who 
appear to do poorer after transplantation 
than whites or other minority groups. 
The reasons for this are unclear but may 
relate to the fact that American Blacks are 
disadvantaged from the cradle to the 
grave for the following reasons:
“1. They are born weighing less than 
whites.
2. They have twice the infant mortality 
rate of whites.
3. Their life span is 4-5 years shorter 
than whites.
4. They have hypertension 3-4 times as 
frequently as whites.
5. They suffer end stage renal disease 
from hypertension 17 times as fre­
quently and end stage renal disease, 
in general, four times as frequently as 
their white counterparts.”
Among some of the other facts he 
shared during his testimony: that 70 per­
cent of the patients who are on dialysis in 
the southeastern part of the United 
States are Black; that Blacks do 10-20 
percent poorer after transplantation than 
whites; that the District of Columbia, 
with its 70 percent Black population, has 
the highest incidence of renal disease in 
the United S ta te s .“These shocking 
facts,” he emphasized, “indicate that 
Blacks suffering from end stage renal dis­
ease require special treatment and are a 
population that must be listened to.”
The Howard Center
The Howard University Hospital Trans­
plant Center is the only transplant center 
in the nation affiliated with a predomi­
nantly Black university. And the special 
population it serves — of whom and for 
whom Dr. Callender spoke so forcefully 
during that testimony — has shaped not
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transplants but the role it has carved out 
for itself in the larger medical-socio­
political community.
The center dates back to 1970 when 
Dr. LaSalle Leffall, chairman of the de­
partment of surgery of what was then 
Freedmen’s Hospital, suggested that Dr. 
Callender, who had been chief resident in 
surgery the previous year, apply for a 
special postdoctoral fellowship in trans­
plant immunology at the University of 
Minnesota, a national leader in organ 
transplantation. Dr. Callender received 
the fellowship, spending two years under 
the tutelage of noted transplant surgeon 
Dr. John Najarian, and returned to How­
ard in 1973 to launch a transplant center 
[See Box: “God Should Have the Glory.”] 
In November 1975, following a con­
certed lobbying effort, Howard’s center 
received certification from the Depart­
ment of Health, Education and Welfare, 
thus making it eligible to receive federal 
reimbursement for transplant operations. 
(A typical transplant, including pre- and 
post-operative hospital care, costs about 
$20,000; complicated cases run much 
higher. Thanks to special legislation, 
most kidney transplants are now covered 
by Medicare.)
Through the years, the center has 
been able to tally up some important 
achievements:
■ It was the first transplant center in the 
Washington area to use the drug an­
tilymphocyte globulin (ALG) to re­
verse kidney rejection and the second 
in the nation to experiment with total 
lymphoid irradiation as an anti-rejec­
tion treatment.
■ It has shown remarkable success in 
transplanting and rehabilitating a group 
of patients many hospitals dismiss as 
hopeless — heroin addicts — and has 
innovated in the use of group therapy 
for all its patients.
■ It has conducted research in such areas 
as pancreatic transplants, organ pres­
ervation and the pretreatment of kid­
neys with ALG and has helped medical 
students, interns and residents be­
come more knowledgeable about 
transplantation.
■ It has played a small but significant role 
in enlarging the pool of the nation’s 
Black transplant surgeons. (Consider, 
for example, the fact that only three of 
the 303 members of the prestigious 
American Society of Transplant Sur­
geons are Black.) Dr. Joel Stevens, the 
center’s assistant director, was trained 
in transplant surgery both at Howard 
and the University of Minnesota. He 
has been followed by Dr. Jock Simon, 
currently receiving special training in
kidney, liver and pancreatic transplants 
at the University of Minnesota. He is 
expected to rejoin the staff of the How­
ard center in May.
■ It also has extended its training and 
treatment efforts beyond the continen­
tal United States. (Since October 
1982, the Howard center has been in­
volved in training a medical team in the 
U.S. Virgin Islands to do kidney .trans­
plants. The first transplant the joint 
Howard-St. Thomas Hospital medical 
team performed on the islands on De­
cem ber 14, 1982 received major 
coverage in St. Thomas newspapers 
and on television and was hailed by the 
governor as heralding “a new plateau in 
the quality of health care now available 
in the Virgin Islands.” In dedication
NEW DIRECTIONS APRIL 1984 4
New Directions, Vol. 11 [], Iss. 3, Art. 2
http://dh.howard.edu/newdirections/vol11/iss3/2
ceremonies in February 1983, St. 
Thomas Hospitals new transplant cen­
ter was named after Dr. Clive 
Callender. As of this writing, the cen­
ter had performed six kidney trans­
plants, with all but one still functioning. 
Plans call for the Virgin Islands trans­
plant team to be completely autono­
mous in two years.)
Given the center’s accomplishments 
and given the national reputation it has 
earned, few on the Howard campus were 
surprised in April 1982 when it received 
the university’s Outstanding Achieve­
ment Award in the Division of Health Sci­
ences.
As an organizational entity, the trans­
plant center serves as the surgical arm of 
Howard University Hospital’s renal unit.
As a physical entity, it consists of various 
offices, laboratories, treatm ent and 
operating rooms within the hospital. But 
the center is also people, people who 
work together as a team. It is transplant 
surgeons (Drs. Callender and Stevens.) It 
is surgeons with other specialties (Dr. 
Aaron Jackson, a urologist who heads the 
team operating on kidney donors; Dr. 
Oswald Warner, a specialist in vascular 
access, i.e. providing a connection be­
tween artery and vein, a preliminary step 
that is necessary for hemodialysis). It is 
specialized nurses (Josephine Flores and 
Patricia Dillard); a social worker (Earlene 
Reavies); a dietician (Sylvester White); a 
perfusionist (Rodney Smith) who is in 
charge of organ preservation; a transplant 
coordinator (Curtis Yeager) who pulls to­
gether all aspects of the center’s work; 11 
secretaries (Loyce Battle and Thelma 
Washington) who take care of its detailed 
paperwork. Working closely with the staff 
of the transplant center are nephrologists 
(Drs. Adrian Hosten, Martin Dillard and 
Iluminado Cruz) who recommended pa­
tients for transplant and care for them 
when they are on dialysis.
The Surgical Procedure
When a dialysis patient is deemed suita­
ble for a transplant and he or she wants a 
transplant, the center’s mechanisms start 
rolling. Transplant coordinator Yeager 
explains how:
Family members of the patient are 
brought together to see if any of them 
would be willing to donate a kidney. If so, 
they are tested to see if their blood and 
tissues are compatible with those of the 
patient. The best donor in the family is 
then identified, someone who not only 
has compatible blood and tissues, but is 
also in good general health. If that person 
decides to donate, the case is scheduled, 
patient and donor are matched and 
brought into the hospital for the actual 
operation. (Having just one kidney gen­
erally causes no particular problems be­
cause one kidney is able to do all the work 
of two. Some people, in fact, are born 
with one kidney.)
If no relatives are willing or able to do­
nate a kidney, information about the pa­
tient’s blood and tissue type is put on a 
computer listing which goes out all over 
the country in hope that somewhere a 
compatible kidney will be found from 
someone who recently has died and had 
agreed to organ donation. (The ideal 
donor would be someone who had been in 
good health but died suddenly — from a 
gunshot wound or in a car accident, for 
instance.) Once a suitable kidney is lo­
cated, the hospital in question is informed 
of the Howard center’s need for it and
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of essence. A kidney removed from a 
cadaver will only be good for transplanta­
tion for 37 hours (when packed in ice) or 
72 hours (when put in a special renal 
preservation machine.)
The actual operation varies depending 
on whether the kidney comes from a 
cadaver or a living relative. Dr. Joel Ste­
vens gives the highlights of a typical 4-6 
hour donor-recipient operation:
An incision is made, usually on the re­
cipient’s right lower abdomen, and the 
large blood vessels are exposed just 
above the thigh. At the same time, the 
donor is being operated on in an adjoining 
room. The donor operating team takes 
out a kidney, the one that previously has 
been identified as best for transplant, 
closes up the spot from which the kidney 
has been removed and closes up the ab­
domen.
Meanwhile, with great care, the recip­
ient operating team hooks up the kidney 
in this manner: The vein of the donor kid­
ney is attached (using sutures) to one of 
the large veins that has been exposed and 
similarly the artery of the kidney is at­
tached to the artery that has been ex­
posed. Then the recipient’s bladder is ex­
posed and hooked up to the ureter of the 
donor kidney. The abdomen is then 
closed, completing the surgical proce­
dure. Generally, the transplanted kidney 
starts working immediately.
In some cases, a surgeon will have re­
moved the recipient’s old kidneys in an 
earlier operation, in other cases they 
would have been left in, depending on in­
dividual circumstances.
During surgery, the greatest risks to 
the transplant recipient come from any 
adverse reactions to the anesthetic and 
from excessive bleeding, Dr. Stevens 
points out. After the operation, the 
biggest threats become infection and re­
jection, although sometimes bleeding still
A M other’s Story
Feeling helpless as your child wastes away before your very 
eyes is undoubtedly the greatest torment a parent can en­
dure. Here Doris Dotson, a Nashville mother, speaks o f her 
daughter Tomeka’s struggle with kidney disease and the 
road both o f them took so that Tomeka could have a more 
norm al life. H er’s is a story o f pain and anger, o f courage 
and hope.
A t the age of four, Tomeka—  who had always been tiny—  seemed to be gaining a little weight. Suddenly one night 
her whole abdomen sort of swelled up 
and we took her to the emergency 
room and her pediatrician called in a 
nephrologist. At the time it was de­
termined that she did, in fact, have a 
kidney problem: protein was spilling 
through her urine and causing her body to swell. It was called 
nephrotic syndrome. For two years, while she was on medication 
for that, we were hoping and praying the problem would go away. 
Instead, it turned worse. Christmas 1982 her kidneys totally 
failed.
She was put on peritoneal dialysis, the quickest and shortest 
kind of dialysis, because it was determined that my tissues were 
compatible and I could donate a kidney to her for a transplant. No, 
I wasn’t frightened to give up a kidney — even though a lot of 
people tried to talk me out of it. They said, ‘Why would you 
endanger your own life?’ and ‘Why don’t you just wait for a kidney 
to come, a cadaver kidney?’ and ‘Shouldn’t you think about your 
own health, after all, you have two other children?’ and things like 
that. But I didn’t want to hear those kinds of things. The only thing 
that did frighten me was that my baby was so ill and I couldn’t help 
her. When I found out I could help her [by donating a kidney], 
there was no question in my mind about what I would do.
Since February [’83] we had been in consultation with a white 
doctor at Vanderbilt Hospital about having the operation. I was 
under the impression we would get a kidney transplant about May 
because I work with the school system [as a teacher’s assistant 
for handicapped children] and I wanted to have enough time to 
recuperate before school started. Around July 1st I still hadn’t 
heard anything and I was getting worried because soon it would 
be time for me to go back to work and also because Tomeka wasn’t 
doing any better. Also, by this time, with the worrying and all, I 
had picked up some weight. So this white doctor said that I was 
overweight and that he couldn’t do the surgery— even though he
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had never tested me or even gotten a history of my health or 
anything! — and that Tomeka would have to go on hemodialysis.
On the day she was being operated on to get the fistula [a 
surgical joining of artery and vein beneath the skin done so that 
hemodialysis can take place] I really shrilled out. I just got so 
distraught because I couldn’t go through seeing her go through 
hemodialysis, couldn’t see her being a slave to that machine. That 
same day someone had told us that there was a kidney center up at 
Howard University. While Tomeka was still in surgery, my hus­
band called Mr. Yeager [Curtis Yeager, transplant coordinator for 
the Howard center] and told him about our situation, telling him 
how my weight problem was supposed to be the reason for the 
holdup of the transplant here. Mr. Yeager said he and Dr. [Clive] 
Callender were supposed to be at a conference in Nashville in 
about two weeks and would be glad to look at us.
They came and when they saw me, they laughed. They said 
they were looking for a lady three feet tall and three feet wide. 
They said I didn’t seem to have a weight problem as far as they 
were concerned. The next day they went to Tomeka’s doctor’s 
office and they examined her and told me how terrible she looked 
and asked why anyone would wait to do the surgery. Later I 
learned that when they were talking among themselves outside 
the clinic doors they said that Tomeka wasn’t going to make it very 
long [without a transplant], that she was, in fact, dying. Dr. 
Callender asked me if I was still ready to have the surgery. I told 
him, ‘Yes.’ He said, ‘How soon can you come?’ So, naturally, I 
said, ‘Two or three weeks. ’ He said, ‘No, I’m not even going to ask 
you. Be there next week. ’
So we went and stayed up there at Howard University Hospital 
21 days. The date of the operation was September 16,1983. The 
hospitality of the patients and the workers and the medical attend­
ants really helped me a lot to not be afraid. It was the first time I’ve 
ever been in an experience where the medical people themselves 
actually presented God as some type of strength for me to hold 
onto. And this is a big part of what gave me confidence in Dr. 
Callender because he told me that he could do 150 percent and 
God would have to do the rest. And I really liked that. Because I 
think you have to believe. I’m serious. It really does help. . . .
Since the operation we’re both doing great. Tomeka’s on a few 
medications, two of them she’ll have to take for the rest of her life 
or the life of the kidney. She had to learn her medications and 
dosages and she does well with them. We put her medications in a 
little case and she takes them with her to school.
Tomeka turned seven last October 30th. Before the surgery, 
she was listless and didn’t want to do anything. Since the surgery, 
she’s had a 360 degree turnaround. She’s able to play now. She 
does real well in school and has made the principal’s honor roll. 
Before, she was sick every day, every day. Now, she’s really 
enjoying life. □
can be a problem. Before, during and 
after surgery, the patient is given im­
munosuppressive drugs, drugs which 
suppress the body’s natural tendency to 
attack foreign substances (in this case, 
the transplanted kidney). But in suppres­
sing the immune system so the body can 
keep the kidney, the body is less able to 
fight off any invading germs, thus becom­
ing much more vulnerable to infection. 
“That’s why reaching the precise level of 
immunosuppression remains such a chal­
lenge,” Dr. Stevens points out.
Some rejection episodes can be re­
versed by temporarily increasing the 
dosage of immunosupressive drugs. That 
was the fortunate denouement of that 
scene with Denise Chasten in the hospi­
tal’s intensive care unit. She was able to 
keep her kidney. If a rejection episode 
cannot be reversed, the patient returns to 
dialysis and may opt for another trans­
plant later on.
Because Blacks statistically do less 
well after transplantation than whites, the 
Howard center has evolved some special 
modes of treatment to deal with this prob­
lem, Dr. Callender explains. Before a 
transplant operation, a patient’s kidneys 
may be removed to control hypertension 
(far more prevalent amongst Blacks than 
whites). The spleen also may be removed 
to raise a patient’s white blood count 
(which is generally lower in Blacks than 
whites) so that the use of immunosup­
pressive drugs is less likely to cause in­
fection and to raise his platelet count so 
there is less chance of excessive bleed­
ing. Because the center also has found 
that Blacks tend to tolerate steroid anti­
rejection drugs less well than whites, it 
makes greater use of the non-steroid 
drug, antilymphocyte globulin, to fight re­
jection than do centers treating predomi­
nantly white patients.
Once a patient has been operated on 
successfully, he continues to be closely
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monitored for signs of rejection and infec­
tion. He or she also must learn to cope 
with a new identity as a transplant recip­
ient. And this is where the center’s regu­
lar Thursday morning therapy sessions 
play such an important role.
Group Therapy
These sessions bring together those 
who are awaiting transplants, those who 
have had successful transplants, those 
who have been rehospitalized following 
complications with their transplants and 
sometimes family members of those in 
each category.
One recent Thursday, a dialysis patient 
awaiting transplant told of his yearning for 
that which most people take for granted: 
a glass of water. (Patients on dialysis 
must severely restrict their fluid intake.) 
Some who have had transplants worried 
aloud about one of the side effects of their 
anti-rejection medications: bone deteri­
oration. A father of a patient awaiting a 
transplant spoke of the way his son’s frus­
tration caused him to lash out at every­
one, while a patient who already had re­
ceived a transplant told of how she once 
had interpreted her family’s concern for 
her health as an attempt to smother her.
“One of the main problems transplant 
recipients face,” says social worker Ear- 
lene Reavies, “is that at some point they 
forget that the kidney is not theirs, that 
they weren’t born with it, that if they stop 
taking their medicine, they’re going to re­
ject. It’s a psychological step they go 
through. So you have to remind them that 
the kidney is not theirs.” She’s also found 
that sometimes patients have trouble ad­
justing to a more normal lifestyle after 
being dependent on dialysis for a long 
time or that they refuse to listen to “the 
bad stuff” about transplants so when 
something goes wrong, even though 
they’ve been told all the risks, they feel 
betrayed. Then there is all the anxiety
God Should Have 
the Glory’
When Dr. Clive Callender fin­ishes a successful opera­tion, his face lights up with jubilation, e rasin g  the  
fatigue etched around his eyes and mak­
ing his short crop of greying hair look as 
if it must belong to someone else.
Yet the boyish-looking demeanor of 
the nationally-recognized transplant 
surgeon seem s to mask a complex, 
driven and often enigmatic personality.
He tells you of some of the dismal events 
of his childhood— his mother dying during a home delivery when 
he and his twin brother were coming into the world, a year spent 
in a foster home, a year and a half spent in a hospital with tuber­
culosis — and then says, “None of those things really bothered 
m e.” He’s on the phone, laughing uproariously and exchanging 
anecdotes about his favorite basketball team, the Bullets, and 
later switches gears to speak in spiritual tones about the profound 
impact religion has had on his life.
He admits that to work as hard as he does is “insanity, ” that he’s 
surprised he’s not dead because of the abuse his body has taken 
from his hectic schedule, and then tells his secretary to make a 
plane reservation for him for tonight because he has to go back to 
the Virgin Islands to check on a patient. He tells you he’s already 
achieved his childhood dreams —  to be a doctor and to serve in 
Africa — and now feels he has “no more miles to conquer” and 
then enthusiastically shares his hope that the Howard University 
Hospital Transplant Center become a national referral center for 
Black transplant patients, that it open its doors to Black patients 
from all over the nation and the world, that it go into other types of 
transplants.. . .
The man at the center of these contrasts was born in Harlem 48 
years ago. There he and his twin brother were raised by a dedi­
cated and devout aunt following the death of their mother, the 
remarriage of their father to a woman whose own problems made 
childrearing impossible and that year-long stay in a foster home. 
(Carl Callender is a prominent New York attorney and minister. 
That the two brothers have become Harlem success stories in­
stead of Harlem casualties, Dr. Callender attributes to two fac­
tors: “our aunt and our religious background. ”)
Dr. Callender says he decided to become a doctor when he was 
seven. “One day in church something the minister said struck a 
chord, ” he recalls. “He said, ‘The best way you could serve man-
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kind was to minister to the body and soul of mankind.’ And I 
thought I could best do that by becoming a doctor. ” Why would a 
seven-year-old be concerned with something as lofty as “minister­
ing to the body and soul of mankind?” “I thought that was the 
ultimate thing to do with your life, ” he answers as if it was the 
most obvious thing in the world, something any dummy would 
know.
Among the landmarks along his journey to fulfilling his child­
hood dream of a medical career: Hunter College in New York; 
Meharry Medical College, where he finished first in his class; 
Howard University’s Freedmen’s Hospital, where he did his resi­
dency in surgery; Port Harcourt General Hospital in eastern 
Nigeria, where he was a consultant in surgery; the University of 
Minnesota, where he received advanced training in transplant 
surgery; Howard University, to which he returned after that train­
ing and where he now is not only director of the transplant center 
but vice chairman of the department of surgery in the hospital and 
college of medicine; St. Thomas Hospital in St. Thomas, the U.S. 
Virgin Islands, which has named its transplant center in his honor 
for his work in making transplants available to the local populace.
Dr. Callender says he was initially attracted to transplant 
surgery because “it was a new and challenging field. ” Through the 
years, he estimates, he’s been involved in between 400 and 500 
kidney transplant operations. Through the years, too, he’s re­
ceived so many awards and honors, participated in so many pro­
fessional organizations, made so many presentations in so many 
varied settings, authored or co-authored so many research papers 
that his curriculum vitae runs to 27 closely-typed pages.
Yet he seems uncomfortable in the limelight (“shy” is the word 
one of the center’s secretaries uses to describe him) and tries to 
deflect all the praise that has come his way for the successful 
transplants he’s performed. For one, he emphasizes, the trans­
plant effort is a team effort with many people contributing their 
expertise and concern. For another, he jokes, “I don’t like too 
much praise because if you can get too much praise, you can get 
too much criticism — and I don’t like that.” But there’s another 
reason and it’s a reason that relates to the depth of his religious 
beliefs:
“I do what I know how to do. I put a kidney in and draw on my 
knowledge and training to do the best job I possibly can. But 
whether the transplant is successful or not is not up to me. It’s up 
to God. I tell my patients we’ll do all we possibly can but I also tell 
them that God is the final arbiter. And we ask them to pray that 
God will direct us and guide us because I’ve always felt that in all 
things God should have the glory. ” □
that can build up as they wonder if a 
transplanted kidney will fail and “the 
stages of depression and loss and mourn­
ing” they go through if it does.
The Thursday morning sessions are 
the place where transplant patients feel 
free to drop the masks they wear out in 
the world and reveal their innermost 
feelings about what is bothering them. It’s 
also the place where they can join to­
gether to grope for solutions to common 
problems. The sessions serve to further 
patient education as well.
“The key to the whole thing in trans­
plantation is self-care,” says Patricia Dil­
lard, nursing supervisor for the center. 
“We do whatever we have to do. We con­
nect the kidney. We adjust the medica­
tions. But if the patients are sent out 
without a good understanding of what’s 
going on from point A on, we can’t even 
think about success. The patient has to 
understand that if he misses one dose of 
prednisone [an immunosuppressive] that 
could mean he could reject— not just be­
cause we say so, but because he under­
stands transplants. He understands that 
a, b, c, d are the signs of rejection so 
therefore if he doesn’t take his prednisone 
which has a, b, c, d side effects then he 
has a chance to reject his kidney. ”
Indeed, as a result of the group therapy 
sessions, even those patients with limited 
formal education speak knowledgeably 
about platelets, white blood counts, ALG 
(antilympocyte globulin), creatinine. . .
Public Education and Advocacy
While the group therapy sessions reflect 
the center’s goal to have “an informed pa­
tient and an informed family,” as trans­
plant coordinator Yeager puts it, the cen­
ter’s staff also has been involved in a 
larger educational effort: to spread the 
word about the importance of organ 
transplantation and donation and to en­
courage more people, especially Black
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people, to will their organs after death.
A Gallup Poll commissioned by the Na­
tional Kidney Foundation found that 95 
percent of whites were knowledgeable 
about organ transplantation, compared to 
84 percent of Blacks and that while 27 
percent of whites were willing to donate 
their organs after death, only 10 percent 
of Blacks were willing to do so. A National 
Kidney Foundation of the National Capital 
Area press release also noted that in the 
District of Columbia, where 70 percent of 
the kidney patients are Black, fewer than 
20 percent of the donors are Black.
One preliminary study conducted by 
Howard University researchers found 
that the most common reason Black re­
spondents gave for not willing their or­
gans was lack of information. This, in 
turn, made many superstitious.
Some expressed fears about being cut 
up after death. (Dr. Callender’s response 
to this fear: “Everybody gets cut up after 
death — unless they get cremated. If 
you’re going to be embalmed, they cut 
you up anyway. Besides, after you’re 
dead you don’t have any pain. ”)
Some were afraid they wouldn’t be able 
to “get into heaven” if their bodies were 
not completely intact. (Again, Dr. 
Callender’s response is to cite the em­
balming procedure, adding, “So you’re 
not going intact anywhere [after death]. ”)
Then there were those who expressed 
apprehension that if they will their or­
gans, when they are sick in a hospital they 
will not receive proper care because the 
doctors will be so eager to pluck out their 
organs and give them to someone else. 
(Dr. Callender’s answer: “Basically, the 
doctors who determine whether you’re 
alive or dead neurologically are com­
pletely separate from those doctors who 
are going to do transplants. That separa­
tion should always exist. ”)
Dr. Callender currently serves as 
chairman of the D.C. Organ Donor Proj­
ect, a pilot project supported by the Na­
tional Kidney Foundation, which aims to 
help Black Washingtonians overcome 
their reluctance to donate kidneys. The 
project includes conducting an education 
campaign through the Bureau of Motor 
Vehicle Services in which drivers seeking 
licenses are given information about 
organ donation and given the option of 
having their licenses stamped on the spot 
if they wish to be classified as donors. It 
also includes developing and implement­
ing a lesson plan for the D.C. public
schools that covers organ donation and 
utilizing the media and community meet­
ings to spread the word about its im­
portance.
For the Howard center’s staff, the ra­
tionale for such an educational project is 
self-evident. Says Dr. Callender, who has 
signed an organ donor card himself: “Here 
we are in the District of Columbia, which 
has the highest incidence of renal disease 
in the nation, so it seems to make sense 
to leave our organs behind when we die so 
that other Blacks who suffer from this af­
fliction could have an improved quality of 
life. We talk about doing things to help 
each other, so here is the greatest time to 
help ... After you die, you’re not going to 
use your organs anyway. ”
Not only has Dr. Callender and his staff 
been involved in bringing the transplanta­
tion perspective to Blacks, but they also 
have been instrumental in bringing the 
Black perspective to transplantation. In 
Congressional and other testimony, Dr. 
Callender has warned that most minority 
persons cannot afford cyclosporin A, a 
major new anti-rejection drug that is 
being hailed as a breakthrough in trans­
plantation. (The drug costs approxi­
mately $5,000 a year and is not covered 
by Medicare as is true for all out-of­
hospital transplant medications. So if one 
is not eligible for Medicaid, one would 
have to foot this hefty bill.)
He also has spoken out against the en­
tire idea of organ selling. (Several bills 
have been introduced into Congress to 
ban this most controversial variant of 
“free enterprise.” Efforts to get such a 
bill passed came after widespread public­
ity about a Reston, Va. man’s intent to 
open a profit-making organ brokerage 
firm.)
“Selling organs is the worst thing that 
could happen to transplant surgery, ” says 
Dr. Callender, with vehemence. “What 
would happen is that Blacks — again — 
would be victimized. Someone would say 
to some Black guy, 'Here’s $20,000 for 
your kidney so we can give it to someone 
else.’ It is my belief that organ selling 
would result in the socioeconomically- 
deprived groups being abused arid for that 
reason I am as strongly opposed to it as I 
could possibly be.”
Concern with the victimization of 
minorities also has fueled the center’s in­
terest in doing liver transplants. “We 
hope to be able to offer liver transplanta­
tion to minorities who, at this point, are
discriminated against because they don’t 
have the funds,” Dr. Callender observes. 
“Liver transplants are not covered by 
Medicare so most of the white folks who 
have transplants raise funds. It’s easy to 
figure out that it’s much easier for a white 
person to raise funds among whites for a 
liver transplant than for a Black person to 
raise funds among Blacks for one. If a 
Black person goes to his friends, he might 
raise $200 or $1,000. But when we talk 
about a liver transplant, we’re talking 
about $50,000 to $100,000.”
As he looks to the future of the Howard 
University Hospital Transplant Center, 
Dr. Callender also envisions it evolving 
into a referral and treatment center for 
Black transplant patients from all over the 
nation.
It seems an overreaching dream. But 
then, again, so did the whole notion of 
kidney transplantation, itself, at one 
time. That the dream is now a reality is 
something for which the Scottie Left- 
dwriges of this world are most grateful. 
Amen. □
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